Mammoth Biosciences collaborated with GSK to develop COVID-19 test using CRISPR-based platform
On May 20, 2020, Mammoth Biosciences announced a collaboration with GSK Consumer Healthcare to develop an accurate, easy-to-use,…
Kindred Biosciences announced COVID-19 vaccine manufacturing agreement with Vaxart
On May 20, 2020, Kindred Biosciences announced it had entered into an agreement with Vaxart for the manufacture…
Vaxart announced selection of its oral COVID-19 vaccine lead candidate
On May 20, 2020, Vaxart announced it had selected its lead COVID-19 vaccine candidate and had contracted with…
ViralClear closed $108 million equity financing for development of COVID-19 broad-spectrum oral anti-viral candidate merimepodib
On May 20, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the closing of a $10.8 million…
Rapid Micro Biosystems raised $120 million to accelerate global expansion of contaminant testing platform for pharmaceutical and vaccine manufacturing
On May 20, 2020, Rapid Micro Biosystems announced a $120 million financing round, led by equity investment from…
CHF Solutions publication highlighted use of ultrafiltration for fluid management in COVID-19 patients
On May 20, 2020, CHF Solutions announced a publication highlighting the use of ultrafiltration for fluid management of…
Airway Therapeutics and Celonic Group collaborated to produce AT-100 as promising new candidate for Coronavirus
On May 20, 2020, Airway Therapeutics and Celonic Group announced a collaboration to produce the novel human recombinant…
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Bharat Biotech and Thomas Jefferson University announced a promising vaccine candidate against COVID-19
On May 20, 2020, Bharat Biotech and Thomas Jefferson University of Philadelphia announced an exclusive deal to develop…
Diffusion Pharma expanded clinical trial program of TSC for treatment of COVID-19 patients to include Romanian National Institute of Infectious Diseases
On May 20, 2020, Diffusion Pharmaceuticals announced it had entered into an agreement with the Romanian National Institute…
Atossa Therapeutics announced in vitro testing results of COVID-19 drug inhibits SARS-CoV-2 infectivity
On May 20, 2020, Atossa Therapeutics announced the successful results from in vitro testing of AT-H201, Atossaﾒs proprietary…
NIH-funded study investigated pregnancy outcomes resulting from COVID-19 pandemic
On May 19, 2020, the NIH has launched a multipronged study to understand the effects of the COVID-19…
Oxford Immunotec released T-SPOT Discovery SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2
On May 19, 2020, the University of Oxford announced the release of the T-SPOT Discovery SARS-CoV-2 test kit….
The FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to accelarate Coronavirus disease research
On May 19, 2020, the FDA announced an agreement with Aetion to collaborate on advanced analytical techniques to…
Llama antibody engineered to block Coronavirus
On May 19, 2020, the NIH rported that researchers from the University of Texas, in collaboration with a…
USC antibody study showed coronavirus infection more widespread in LA County than previously thought
On May 19, 2020, a University of Southern California (USC) study reported results from the first phase of…
Antibodies produced in response to one type of coronavirus don’t offer protection against the other, study suggests
On May 19, 2020, in a study published in Cell Reports, researchers at the University of Hong Kong…
Oragenics and Aragen Bioscience enter agreement to accelerate development of TerraCoV2, a SARS-CoV-2 (COVID 19) vaccine candidate
On May 19, 2020, Oragenics announced, that through its wholly-owned subsidiary, Noachis Terra, it has entered into an…
Innovation Pharma’s Brilacidin reduced viral titer of SARS-CoV-2 by 75 percent after 1 hour of preincubation in an in vitro study
On May 19, 2020, Innovation Pharma announced that its anti-SARS-CoV-2 (COVID-19) drug candidate, Brilacidin, in an in vitro…
Bio-Techne and Kantaro Biosciences announced partnership to develop and scale production of COVID-19 serology test
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
Roche highly accurate antibody test for COVID-19 went live at more than 20 initial lab sites in the US
On May 19, 2020, Roche announced its Elecsysﾮ Anti-SARS-CoV-2 antibody test is live at more than 20 commercial…
New study from pandemic epicenter described severe COVID-19 response in children
On May 19, 2020, the Albert Einstein College of Medicine reported that while most children infected with the…
Phlow Corp was awarded $354 million BARDA contract to manufacture essential medicines in shortage
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
CytoDyn and the Mexican National Institutes of Health announced a collaborative study of leronlimab for treatment of severe/critical COVID-19 Population
On May 19, 2020, CytoDyn announced it will be coordinating with the NIH of Mexico and providing leronlimab…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | NIH | Therapeutics
Autism risk estimated at 3 to 5% for children whose parents have a sibling with autism
On May 18, 2020, the NIH reported that roughly 3 to 5% of children with an aunt or…
Long-acting injectable drug prevents HIV among men and transgender women
On May 18, 2020, an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks…
Global study tested malaria drug to protect health workers from COVID-19
On May 18, 2020, with $9 million from the COVID-19 Therapeutics Accelerator, an international group of physicians and…
NantKwest announced FDA authorization of IND application for mesenchymal stem cell product for treatment of severe COVID-19 patients
On May 18, 2020, NantKwest announced it had received authorization from the FDA for an Investigational New Drug…
Quidel’s Lyra Direct SARS-CoV-2 assay received Emergency Use Authorization and CE Mark for molecular detection of COVID-19
On May 18, 2020, Quidel announced it had received Emergency Use Authorization (EUA) for the Lyra Direct SARS-CoV-2…
FDA cleared IND application to enable phase II trial of ViralClearﾒs merimepodib to treat adult patients with advanced COVID-19 to proceed
On May 18, 2020, BioSig Technologies and its subsidiary, ViralClear Pharmaceuticals, announced the FDA has completed its review…